News and Blogs

GMHHF Donates Ultrasound System to HackensackUMC’s Pediatric Center for Heart Disease

Posted on July 14, 2016

The best way to prevent sudden cardiac death is through comprehensive screenings, and at GMHHF, we want to make this possible for as many people as possible. Recently, GMHHF donated a Philips EPIQ 7 Ultrasound system to the Pediatric Center for Heart Disease, a division of the Joseph M. Sanzari Children’s Hospital at HackensackUMC, which also houses the Gregory M. Hirsch Center for Hypertrophic Cardiomyopathy. Section chief of Pediatric Cardiology Dr. Robert Tozzi explained that this advanced system produces extremely detailed images that...

NJBIZ Names GMHHF Healthcare Heroes Finalist

Posted on

The Gregory M. Hirsch Heart Foundation was recently honored as a finalist in the NJBIZ Healthcare Heroes awards program, which honors individuals and organizations that are making a significant impact on the quality of health care in New Jersey. GMHHF was nominated in the category of Education Hero – Organization for demonstrating heroic actions in the health care industry, including providing health care education services and free heart screenings for New Jersey students. In the most recent issue of NJBIZ, GMHHF Founder &...

Puppy love may help heart health

Posted on April 29, 2016

A new study finds that owning a dog may reduce risk of suffering heart attack or stroke, especially for those who live alone. The American Heart Association released a statement last year attesting to this fact, and a recent Swedish study found that dog ownership can be particularly beneficial for those who live alone, who are at higher risk. This may be due to dog owners partaking in more exercise by walking their dogs, or due to the fact that owning a dog can reduce the risk of depression. Read more...

Northeastern University developing heart screening process

Posted on April 26, 2016

With the March Madness tournament having recently reached completion, young athletes are at the forefront of national attention. Although these people are usually depicted as the pinnacle of health and athleticism, athletes are susceptible to heart issues as well; every three days, a competitive athlete in America dies from SCD, often due to hypertrophic cardiomyopathy (HCM). Researchers at Northeastern University are looking to identify athletes at risk for SCD. The team is working to develop a pre-participation screening process using...

Heart Health Q&A with Cardiologist

Posted on April 23, 2016

Cardiologist Rachana Kulkarni, MD, is chair of the Department of Medicine at Robert Wood Johnson University Hospital Somerset. Click here to check out an informative Heart Health Q&A with Dr. Kulkarni, which answers some questions you may have about heart disease and how to keep your heart healthy. Learn about the major risk factors of heart disease, including high blood pressure, and warning signs of heart disease, including chest pain. If you are aware of how to keep your heart healthy by following these tips, including integrating...

Study underway to test treatment for HCM

Posted on April 21, 2016

Gilead Sciences, a biopharmaceutical company, has begun the second phase of researching hypertrophic cardiomyopathy treatment. This study includes using HCM treatment candidate eleclazine as well as the iRhythm Zio Patch, a cardio monitoring patch. Researchers are looking to measure changes in arrhythmic burden assessments as a result of the treatment. Read more here and find out more from iRhythm...

The behind-the-scenes of a heart transplant

Posted on April 18, 2016

Many lives are saved each year as a result of successful heart transplants. The steps that go into a heart transplant are vital to execute perfectly in the correct timeline. Typically, more than fifty people are involved in a typical heart transplant, from transportation and delivery to surgery. Read more about the timeline of a heart transplant here.

New medicine in trials may prevent HCM

Posted on April 5, 2016

Human clinical trials are underway for new medicine that may have the ability to prevent and reverse the development of hypertrophic cardiomyopathy. MyoKardia, Inc. developed the drug and conducted a study which found that the medicine worked to prevent development of HCM in mice. Unlike other drugs taken by patients with HCM, this new development focuses on prevention rather than treating the symptoms. Read an article highlighting this study here and access the full publication...

A toast to, perhaps, better heart health

Posted on March 31, 2016

Two studies have found that alcohol in moderation can be beneficial for your heart. Researchers found that people who drank wine, liquor, or beer daily had better cardiovascular health and were less susceptible to heart failure and heart attacks than non-drinkers. Authors of one of the studies stated that alcohol leads to more good cholesterol, but can also cause higher blood pressure. The major takeaway of this study is that having three to five drinks a week can be beneficial for your heart, but any more than that can be detrimental. Read...

New blood test for inherited heart conditions

Posted on March 27, 2016

A new blood test for all known inherited heart conditions has been developed. The research team, comprising international scientists, has pinpointed the particular group of genes from which all known inherited cardiac conditions can be tested. The new test is quicker, less expensive, and more reliable, according to some experts. Read more here.